Skip to main content Accessibility help
×
Home
  • Print publication year: 2009
  • Online publication date: May 2010

Chapter 24 - Nonsurgical treatment of male infertility:

Summary

This chapter discusses the sites of genitourinary tract infections, infectious organisms, the numerous ways in which leukocytes may impair male reproduction, and the diagnosis and treatment of leukocytospermia and bacteriospermia. Infections of the urethra are most common due to sexually transmitted pathogens, and they are separated into two broad categories: gonococcal urethritis (due to Neisseria gonorrhoeae ) and nongonococcal urethritis (Chlamydia trachomatis, Mycoplasma species, Trichomonas vaginalis). Immunohistology employs monoclonal antibodies (mAb) targeted against white blood cell (WBC) surface markers. Flow cytometry, when used in conjunction with monoclonal antibodies, can provide rapid analysis of scant WBC subpopulations without purification procedures. Leukocytes, monocytes, and granulocytes are differentiated by using the light-scatter properties of the WBCs and the density of the leukocyte marker antibody, CD45. The chapter suggests that abnormal concentrations of leukocytes are a common finding in the semen of men with spinal cord injury (SCI).

References

[1] Van ThielDH, GavalerJS, SmithWI, PaulG. Hypothalamic–pituitary–gonadal dysfunction in men using cimetidine. N Engl J Med 1979; 300: 1012–15.
[2] OkadaH, IwamotoT, FujiokaH, et al. Hyperprolactinaemia among infertile patients and its effect on sperm functions. Andrologia 1994; 28: 197–202.
[3] BenoffS, CooperGW, HurleyI, et al. The effect of calcium ion channel blockers on sperm fertilization potential, Fertil Steril 1994; 62: 606–17.
[4] LeeJH, KimH, KimDH, GyeMC. Effects of calcium channel blockers on the spermatogenesis and gene expression in peripubertal mouse testis. Arch Androl 2006; 52: 311–18.
[5] MonoskiM, NudellD, LipshultzL. Effects of medical therapy, alcohol and smoking on male fertility. Contemp Urol 2002; 14 (6): 57–63.
[6] KolodnyRC, MastersWH, KolodnerRM, ToroG. Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med 1974; 290: 872–4.
[7] RossatoM, Ion PopaF, FerigoM, ClariG, ForestaC. Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J Clin Endocrinol Metab 2005; 90: 984–91.
[8] NudellDM, MonoskiMM, LipshultzLI. Common medications and drugs: how they affect male fertility. Urol Clin North Am 2002; 29: 965–73.
[9] ZhuQ, MeisingerJ, EmanueleNV, et al. Ethanol exposure enhances apoptosis within the testes. Alcohol Clin Exp Res 2000; 24: 1550–6.
[10] MostafaT, TawadrousG, RoaiaMM, et al. Effect of smoking on seminal plasma ascorbic acid in infertile and fertile males. Andrologia 2006; 38: 221–4.
[11] DunphyBC, BarrattCL, von TongelenBP, CookeID. Male cigarette smoking and fecundity in couples attending an infertility clinic. Andrologia 1991; 23: 223–5.
[12] GonzalesGF, MuñozG, SánchezR, et al. Update on the impact of Chlamydia trachomatis infection on male fertility. Andrologia 2004; 36: 1–23.
[13] RezácováJ, MasataJ, PribylováM, Drazd’ákováM.Chlamydia trachomatis in men with impaired fertility. Ceska Gynecol 1999; 64: 371–5.
[14] MalallahYA, ZissisNP. Effect in minocycline on the sperm count and activity in fertile men with high pus cell count in their seminal fluid. J Chemother 1992; 4: 286–9.
[15] de BarbeyracB, Papaxanthos-RocheA, MathieuC, et al. Chlamydia trachomatis in subfertile couples undergoing an in vitro fertilization program: a prospective study. Eur J Obstet Gynecol Reprod Biol 2006; 129: 46–53.
[16] SempriniAE, Levi-SettiP, BozzoM, et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 1992; 340: 1317–19.
[17] UmapathyE. STD/HIV association: effects on semen characteristics. Arch Androl 2005; 51: 361–5.
[18] van LeeuwenE, PrinsJM, JurriaansS, et al. Reproduction and fertility in human immunodeficiency virus type-1 infection. Hum Reprod Update 2007; 13: 197–206.
[19] WangY, LiangCL, WuJQ, et al. Do Ureaplasma urealyticum infections in the genital tract affect semen quality? Asian J Androl 2006; 8: 562–8.
[20] AkinJW. The use of clomiphene citrate in the treatment of azoospermia secondary to incomplete androgen resistance. Fertil Steril 1993; 59: 223–7.
[21] HusseinA, OzgokY, RossL, NiederbergerC. Clomiphene administration for cases of nonobstructive azoospermia: a multicenter study. J Androl 2005; 26: 787–91.
[22] WhittenSJ, NangiaAK, KolettisPN. Select patients with hypogonadotropic hypogonadism may respond to treatment with clomiphene citrate. Fertil Steril 2006; 86: 1664–8.
[23] SigmanM, JarowJP. Male infertility. In: WalshPC, RetikAB, VaughanED, WeinAJ, eds. Campbell’s Urology, 8th edn. St. Louis, MO: Saunders, 2002: Vol 2, 1475–531.
[24] MiyagawaY, TsujimuraA, MatsumiyaK, et al. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. J Urol 2005; 173: 2072–5.
[25] ZitzmannM, NieschlagE. Hormone substitution in male hypogonadism. Mol Cell Endocrinol 2000; 161: 73–88.
[26] NishimuraK, MatsumiyaK, TsuboniwaN, et al. Bromocriptine for infertile males with mild hyperprolactinemia: hormonal and spermatogenic effects. Arch Androl 1999; 43: 207–13.
[27] GillamMP, MolitchME, LombardiG, ColaoA. Advances in the treatment of prolactinomas. Endocr Rev 2006; 27: 485–534.
[28] ColaoA, VitaleG, CappabiancaP, et al. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24 month treatment on prolactin levels, tumor mass, recovery of pituitary function and semen analysis. J Clin Endocrinol Metab 2004; 89: 1704–11.
[29] ShimonI, BenbassatC, HadaniM. Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men. Eur J Endocrinol 2007; 156: 225–31.
[30] De RosaM, CiccarelliA, ZarrilliS, et al. The treatment with cabergoline for 24 months normalizes the quality of seminal fluid in hyperprolactinaemic males. Clin Endocrinol (Oxf) 2006; 64: 307–13.
[31] ZöpfgenA, PriemF, SudhoffF, et al. Relationship between semen quality and the seminal plasma components carnitine, alpha-glucosidase, fructose, citrate and granulocyte elastase in infertile men compared with a normal population. Hum Reprod 2000; 15: 840–5.
[32] VitaliG, ParenteR, MelottiC. Carnitine supplementation in human idiopathic asthenospermia: clinical results. Drugs Exp Clin Res 1995; 21: 157–9.
[33] BalerciaG. Placebo-controlled double-blind randomized trial of the use of l-carnitine, l-acetylcarnitine, or combined l-carnitine and l-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril 2005; 84: 662–71.
[34] SigmanM, GlassS, CampagnoneJ, PryorJL. Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial. Fertil Steril 2006; 85: 1409–14.
[35] EbischIM, PierikFH, DE JongFH, ThomasCM, Steegers-TheunissenRP. Does folic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men? Int J Androl 2006; 29: 339–45.
[36] AitkenRJ, KoopmanP, LewisSE. Seeds of concern. Nature 2004; 432: 48–52.
[37] CharlierCJ, FoidartJM. Comparative study of dichlordiphenyldichlorethylene in blood and semen of two young male populations: lack of relationship to infertility, but evidence of high exposure of the mothers. Reprod Toxicol 2005; 20: 215–20.
[38] SkinnerM, AnwayD. Seminiferous cord formation and germ-cell programming: epigenetic transgenerational actions of endocrine disruptors. Ann N Y Acad Sci 2005; 1061: 18–32.
[39] SwanS. Semen quality in fertile US men in relation to geographical area and pesticide exposure. Int J Androl 2006; 29: 62–8.
[40] AgarwalA, et al. Podium presentation. American Society for Reproductive Medicine (ASRM), New Orleans, LA, 2006.
[41] ZahalskyM, WilsonSR, Di BlasioCJ, LamS, NaglerH. Male infertility on the internet: an analysis of web-based resources. BJU Int 2005; 95: 481–4.